| Name | Title | Contact Details |
|---|---|---|
Stan Soper |
Senior Vice President, International and Chief Legal Officer | Profile |
Portola Pharmaceuticals is dedicated to developing and commercializing therapies that transform patient lives and advance patient care by changing treatment paradigms in thrombosis and other hematologic diseases. Our two lead assets are Bevyxxa® (betrixaban), and andexanet alfa. In addition, cerdulatinib is our investigational Syk/JAK inhibitor to treat hematologic cancers. These compounds come from our own internal research efforts and represent important advances to address significant unmet needs. We are employing novel strategies that may increase the likelihood of clinical, regulatory and commercial success of our potentially lifesaving therapies.
Channel Medsystems is a venture-backed company that was founded to bring innovation to the delivery of women’s healthcare. We strive to develop treatments to meet the unique needs of female patients and the high standards of their healthcare providers. We are committed to ensuring that patients have access to high quality outcomes that can be delivered in the convenience and comfort of their healthcare providers office.
General Healthcare Resources is a Plymouth Meeting, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Barnes Health Care Services is a Valdosta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Center for Health Improvement is a Sacramento, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.